Amarin (AMRN) Has Upper Hand in Patent Litigation But Should Settle Anyway - SVB Leerink
Tweet Send to a Friend
SVB Leerink analyst Ami Fadia reiterated an Outperform rating and $29.00 price target on Amarin Corporation (NASDAQ: AMRN), saying while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
